Market Research Reports

Global Array Instruments Market (Life Science And BioTechnology Instruments) - Global Industry Share, Size Growth And Forecast 2011 - 2017

93pages
Published Date: 2012-08-16
 

Description




This report is an effort to identify factors, which will be the driving force behind the array market and sub-markets in the next few years. The report provides extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report has segregated the array industry in terms of product, application and geography. We have used a combination of primary and secondary research to arrive at the market estimates, market shares and trends. We have adopted bottom up model to derive market size of the global array market and further validated numbers with the key market participants and C-level executives. This report highlights the industry with the following points:

  • Definition, estimates & forecast of array product market from 2011 to 2017
  • Analysis of product segments for array product market with historical data and forecast
  • Trends and forecast for four geographic markets, namely U.S., Europe, Asia-Pacific and RoW based on segments of array product market
  • Profiles of major market participants for better understanding of their contributions

This research is specially designed to estimate and analyze the demand and performance of array instruments in a global scenario. The research provides in-depth analysis of array product manufacturers, product sales, trend analysis by segments and demand by geography. The report covers all the major product segments of the global array market and provides historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global array market as below:

  • DNA array
  • Protein array 
  • Cell array 
  • Tissue

On the basis of application, the array market is divided into following segments.
  • Bio pharmaceutical
  • Diagnostic
  • Research laboratories
  • Academics
  • Others


In addition the report provides a cross-sectional analysis of all the above segments with respect to following geographical markets:

  • U.S.
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

The in-depth research and high level analysis will allow array instrument manufacturers, health care industry, dealers and distributors, government bodies and research and development agencies to make informed decisions about array products manufacturing, designing marketing, growth strategies and gaining competitive advantage.

Table of Contents




TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION
1.1 KEY POINTS COVERED
1.2 MARKET COVERED
1.3 RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 ARRAY MARKET OVERVIEW
3.1 MARKET TRENDS AND FUTURE OUTLOOK
3.2 MARKET SIZE
3.3 MARKET SHARE
3.4 GROWTH DRIVERS
      3.4.1 SUPPORT FROM GOVERNMENT INVESTMENT
      3.4.2 INCREASING NUMBER OF CANCER DETECTION
      3.4.3 TECHNOLOGICAL ADVANCEMENT IN HEALTH CARE APPLICATION
      3.4.4 INCREASING APPLICATION OF LIFE SCIENCE
      3.4.5 EFFECTIVE TECHNOLOGY IN DRUG DISCOVERY
      3.4.6 INCREASING COST OF CLINICAL TRIALS IN DRUG DELIVERY
3.5 RESTRAINTS
      3.5.1 COMPETITION FROM OTHER TECHNOLOGIES
3.6 OPPOTRUNITES
      3.6.1 POTENTIAL TEST MARKET SIZE IS VERY LARGE
      3.6.2 INCREASING PER CAPITA EXPENDITURE

CHAPTER 4 ARRAY MARKET BY TECHNOLOGY OVERVIEW
4.1 GLOBAL ARRAY MARKET BY TECHNOLOGY, REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
4.2 DNA ARRAY
      4.2.1 GLOBAL DNA ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
4.3 PROTEIN ARRAY
      4.3.1 GLOBAL PROTEIN ARRAY MARKET REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 
4.4 CELL ARRAY
      4.4.1 GLOBAL CELL ARRAY MARKET REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 
4.5 TISSUE ARRAY
      4.5.1 GLOBAL TISSUE ARRAY MARKET REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 

CHAPTER 5 ARRAY MARKET BY GEOGRAPHY
5.1 ARRAY MARKET SHARE BY GEOGRAPHY - 2011 (USD MILLION) 
5.2 U.S
      5.2.1  U.S ARRAY MARKET REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 
      5.2.2 U.S DNA ARRAY MARKET REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 
      5.2.3 U.S PROTEIN ARRAY MARKET REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 
      5.2.4 U.S CELL ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
      5.2.5 U.S TISSUE ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
5.3 ASIA
      5.3.1  ASIA MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
      5.3.2 ASIA DNA ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
      5.3.3 ASIA PROTEIN ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
      5.3.4 ASIA CELL ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
      5.3.5 ASIA TISSUE ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
5.4 EUROPE
      5.4.1 EUROPE MARKET REVENUE AND FORECAST, 2011 - 2017 (USD MILLION)
      5.4.2 EUROPE DNA ARRAY MARKET REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 
      5.4.3 EUROPE PROTEIN ARRAY MARKET REVENUE AND FORECAST, 2011 - 2017 (USD MILLION)
      5.4.4 EUROPE CELL ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
      5.4.5 EUROPE TISSUE MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
5.5 REST OF WORLD (ROW) 
      5.5.1 ROW ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017, (USD MILLION) 
      5.5.2 ROW DNA ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
      5.5.3 ROW PROTEIN ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
      5.5.4 ROW CELL ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
      5.5.5 ROW TISSUE ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 

CHAPTER 6 ARRAY MARKET BY APPLICATION
6.1  ARRAY TECHNOLOGY BY ITS INDUSTRIAL APPLICATION REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 
6.2 APPLICATION OF ARRAY IN BIO PHARMACEUTICAL INDUSTRY, REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 
6.3 APPLICATION OF ARRAY IN RESEARCH LABORATORIES REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 
6.4 APPLICATION OF ARRAY IN BIO DIAGNOSTICS, REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 
6.5 APLICATION OF ARRAY IN ACADEMICS REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 
6.6 APLICATION OF ARRAY IN OTHERS REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 

CHAPTER 7 COMPANY PROFILE
7.1 NAFFYMETRIX INC. (U.S.) 
      7.1.1 COMPANY OVERVIEW
      7.1.2 FINANCIAL OVERVIEW
      7.1.3 BUSINESS STRATEGIES OF AFFYMETRIX
      7.1.4 AFFYMETRIX, INC. - SWOT ANALYSIS
      7.1.5  RECENT DEVELOPMENT
7.2 ILLUMINA INC. (U.S.), 
      7.2.1 COMPANY OVERVIEW
      7.2.2 FINANCIAL OVERVIEW
      7.2.3 BUSINESS STRATEGIES OF ILLUMINA, INC
      7.2.4 ILLUMINA, INC. - SWOT ANALYSIS
      7.2.5 RECENT DEVELOPMENT
7.3 ROCHE DIAGNOSTICS INC. (SWITZERLAND), 
      7.3.1 COMPANY OVERVIEW
      7.3.2 FINANCIAL OVERVIEW
      7.3.3 BUSINESS STRATEGIES OF ROCHE DIAGNOSTICS LIMITED
      7.3.4 ROCHE DIAGNOSTICS LIMITED - SWOT ANALYSIS
      7.3.5 RECENT DEVELOPMENTS
7.4 BIO-RAD LABORATORIES (U.S.), 
      7.4.1 COMPANY OVERVIEW
      7.4.2 FINANCIAL OVERVIEW
      7.4.3 BUSINESS STRATEGIES OF BIO-RAD LABORATORIES, INC
      7.4.4 BIO-RAD LABORATORIES, INC. - SWOT ANALYSIS
      7.4.5 RECENT DEVELOPMENTS
7.5 LIFE TECHNOLOGIES (U.S.), 
      7.5.1 COMPANY OVERVIEW
      7.5.2 FINANCIAL PERFORMANCE
      7.5.3 BUSINESS STRATEGIES OF LIFE TECHNOLOGIES CORPORATION
      7.5.4 LIFE TECHNOLOGIES CORPORATION - SWOT ANALYSIS
      7.5.5 RECENT DEVELOPMENTS
7.6 CALIPER LIFE SCIENCES (U.S.), 
      7.6.1 COMPANY OVERVIEW
      7.6.2 FINANCIAL OVERVIEW
      7.6.3 BUSINESS STRATEGIES OF CALIPER LIFE SCIENCE, INC
      7.6.4 CALLIPER LIFE SCIENCES, INC. - SWOT ANALYSIS
      7.6.5 RECENT DEVELOPMENTS
7.7 PERKIN ELMER, INC (U.S) 
      7.7.1 COMPANY OVERVIEW
      7.7.2 FINANCIAL OVERVIEW
      7.7.3 BUSINESS STRATEGIES
      7.7.4 PERKIN ELMER SWOT ANALYSIS
      7.7.5 RECENT DEVELOPMENTS
7.8 SIMENS HEALTH CARE (GERMANY) 
      7.8.1 COMPANY OVERVIEW
      7.8.2 FINANCIAL OVERVIEW
      7.8.3 BUSINESS STRATEGIES OF SIEMENS HEALTH CARE
      7.8.4 SIEMENS HEALTHCARE - SWOT ANALYSIS
      7.8.5 RECENT DEVELOPMENTS

LIST OF FIGURES

FIG. 1 GLOBAL ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 2 GLOBAL ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 3 GLOBAL DNA ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 4 GLOBAL PROTEIN ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017, (USD MILLION) 
FIG. 5 GLOBAL CELL ARRAY MARKET REVENUE AND FORECAST, 2011 -2017 (USD MILLION) 
FIG. 6 GLOBAL TISSUE ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 7 MARKET SHARE OF ARRAY MARKET - 2011 (USD MILLION) 
FIG. 8 FORECASTED MARKET SHARE OF ARRAY MARKET – 2017 (USD MILLION) 
FIG. 9 U.S ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 10 U.S. DNA ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 11 U.S. PROTEIN ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 12 U.S. CELL ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 13 U.S. TISSUE ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 14 ASIA ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 15 ASIA DNA ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 16 ASIA PROTEIN ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 17 ASIA CELL ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 18 ASIA TISSUE ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 19 EUROPE ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 20 EUROPE DNA ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 21 EUROPE PROTEIN ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 22 EUROPE CELL ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 23 EUROPE TISSUE ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 24 ROW ARRAY MARKET REVENUE AND FORECAST, 2011-2017 (USD MILLION) 
FIG. 25 ROW DNA ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 26 ROW PROTEIN ARRAY MARKET REVENUE AND FORECAST, 2011 -2017 (USD MILLION) 
FIG. 27 ROW CELL ARRAY MARKET REVENUE AND FORECAST, 2011 – 2017 (USD MILLION) 
FIG. 28 ROW TISSUE ARRAY MARKET REVENUE AND FORECAST, 2011 - 2017 (USD MILLION) 
FIG. 29 TOTAL USE OF ARRAY IN TECHNOLOGY BY ITS INDUSTRIAL APPLICATION
FIG. 30 APPLICATION OF ARRAY IN BIO PHARMACEUTICAL INDUSTRY
FIG. 31 APPLICATION OF ARRAY IN RESEARCH LABORATORIES
FIG. 32 APPLICATION OF ARRAY IN BIO DIAGNOSTICS
FIG. 33 APPLICATION OF ARRAY IN ACADEMICS
FIG. 34 APPLICATION OF ARRAY IN BIO PHARMACEUTICAL INDUSTRY

Enquiry Before Buying




Free Market Analysis





Array instrument is a bio technological tool used for detecting, assessing and analyzing the interaction between different pesticides, sugar, DNA, RNA, proteins, si RNA, pharmaceuticals. Arrays help in research and development of different drug to identify the interaction between various molecules. Use of array technology is one of the important factors for the growth of life science and bio technology instruments. There is large demand for array technology in upcoming years. Life science market is expected to grow with 8% of CAGR. DNA micro array represents the largest market segment in array technology of life science followed by the protein array technology which is expected to grow with 19.7% CAGR by 2015. This report also includes the geographical segmentation and their market share of the total array instrument market. There is large demand for the array in U.S., Europe, Asian and rest of the world by 2017. 

The average expenditure on health care is about USD 2000 per person in the top ten educated countries.. In U.S. per capita expenditure on health care is almost USD 8000 per person. and it is expected to grow in future. As the health care, agriculture and bio chemical industries are growing day by day so there is large opportunity for the test market in future.The U.S. Diagnostic test market is about USD 50.2 to USD 60.4 billion in 2010 and which is expected to grow by 2017. In 2011, U.S dominates the market but the market looks saturated in the coming years but there is large growth expected in Asia pacific market which is driven by emerging countries in this region. Countries like India, China are booming the Asian markets .. 

DNA array market is large market in terms of demand followed by protein array. These market segments are expected to grow in future. DNA array market holds near about 52% and protein array holds about 37% of the total market share in 2011. 

Total revenue generated by array market in year 2011wasUSD 1.464 billion globally. U.S and Europe are the major economies in array technology which are expected to reach the market share of 40% and 33% by 2017 respectively. Asia holds the 21% of market share and revenue generated about USD 307.8 million. Remaining 6% of revenue is generated from rest of the world.
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research